Sharyn N Lewin, MD

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Selected Publications

• First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial. Christian Marth, Richard G. Moore, Mariusz Bidziński, Sandro Pignata, Ali Ayhan, M. Jesús Rubio, Mario Beiner, Marcia Hall, Christof Vulsteke, Elena Ioana Braicu, Kenzo Sonoda, Xiaohua Wu, Sophia Frentzas, André Mattar, Stephanie Lheureux, Xiaojun Chen, Kosei Hasegawa, Manuel Magallanes-Maciel, Chel Hun Choi, Mariia Shalkova, Diego Kaen, Peng Hui Wang, Regina Berger, Chinyere E. Okpara, Jodi McKenzie, Lili Yao, Robert Orlowski, Vivek Khemka, Lucy Gilbert, Vicky Makker, Diego Lucas Kaen, Gonzalo Gomez Abuin, Liliana Beatriz Zamora, Margarita Sonia Alfie, Ignacio Alfredo Casarini, Michelle Harrison, Sumitra Ananda, Catherine Margaret Shannon, Michael Friedlander, Tarek Meniawy, Bo Gao, Sally Baron-Hay, Connie Diakos, Stephan Polterauer, Edgar Petru, Marlies De Bock, Jean Francois Baurain, Toon Van Gorp, Sharyn Lewin, Stephanie Blank. Journal of Clinical Oncology
• The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial. A. Alvarez Secord, S. N. Lewin, C. G. Murphy, S. C. Cecere, A. Barquín, F. Gálvez-Montosa, C. A. Mathews, G. E. Konecny, I. Ray-Coquard, A. Oaknin, M. J. Rubio Pérez, A. Bonaventura, E. J. Diver, S. M. Ayuk, Y. Wang, B. R. Corr, V. Salutari. Annals of Oncology
• Maintenance with mirvetuximab soravtansine plus bevacizumab vs bevacizumab in FRα-high platinum-sensitive ovarian cancer. David M. O'Malley, Tashanna Myers, Pauline Wimberger, Toon Van Gorp, Andres Redondo, David Cibula, Shibani Nicum, Manuel Rodrigues, Floor J. Backes, Joyce N. Barlin, Sharyn N. Lewin, Peter Lim, Bhavana Pothuri, Elisabeth Diver, Susana Banerjee, Domenica Lorusso. Future Oncology

Industry Relationships